A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.

Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...

In primary care settings, the burden of RSV on young children and their guardians often varied between the countries of ...

RSV leads to approximately 1.4 million hospitalizations and over 13,000 in-hospital deaths worldwide among infants under six ...

highlighting the company’s respiratory syncytial virus (RSV) program, will be presented at the 13 th International RSV Symposium (RSV 2025) being held March 12-15 at Bourbon Cataratas do Iguazu, in ...

Among older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively ...

Although the respiratory season in Hungary has eased for the second week in a row, there were still almost 100 children under the age of two in hospital with severe acute respiratory infection, and 57 ...

A new study published in the Journal of American Medical Association showed that nirsevimab offers protection against a ...

MANILA, Philippines — Respiratory Syncytial Virus (RSV) is a common, contagious virus affecting the lungs and breathing passages. It usually causes mild, cold-like symptoms that are often ...

Nirsevimab-resistant respiratory syncytial virus variants remain rare, but continued molecular surveillance is crucial. Read ...

On 12 March 2025, the World Health Organization (WHO) prequalified the first maternal respiratory syncytial virus (RSV) vaccine to protect infants ...